Sol-Gel Technologies Ltd. (SLGL) stock
SLGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 10/30
$55.12−1.13 (-2.01%)
Close on Nov 13, 2026Market cap $153.57MP/E –Yield –
Earnings
Sol-Gel Technologies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
–
Not yet scheduled
Revenue, Q2 FY2025
$17.20M
+218.5% on a year earlier
EPS, Q2 FY2025
$4.17
$0.07 a year earlier
Latest guidance
None
No outlook given in releases
Quarterly results
Revenue and earnings per share from each of Sol-Gel Technologies's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2025ended Jun 30, 2025 | Aug 15, 2025before the open | $17.20M | +218.5% | $4.17 | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 16, 2024before the open | $5.40M | +809.1% | $0.07 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 13, 2024before the open | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 10, 2023before the open | $594.00K | – | $0.22 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 4, 2022during market hours | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 30, 2022before the open | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Sol-Gel Technologies has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Sol-Gel Technologies puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Sol-Gel Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
- 6-K
See a number that looks wrong?